Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2 3 4 5 6 7 8 9

...

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights

October 30, 2024

Biogen (BIIB) Q3 2024 Earnings Call Transcript

October 30, 2024

Biogen's Q3 Profit Beats Expectations On Lower Multiple Sclerosis Revenues But New Products Offset Losses, Raises Profit Outlook

October 30, 2024

This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock

October 23, 2024

Looking Into Biogen's Recent Short Interest

October 22, 2024

After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce

October 17, 2024

Larimar Therapeutics' New Drug Could Transform Treatment For Rare Neurological Disease, Analyst Sees Over 200% Upside For Stock

October 16, 2024

Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe

October 14, 2024

The Latest Analyst Ratings For Biogen

October 10, 2024

After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study

October 08, 2024

Scholar Rock's Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year

October 07, 2024

Looking Into Biogen's Recent Short Interest

October 03, 2024

1 Unstoppable Growth Stock Heading to $2 Trillion by 2030

September 28, 2024

Biogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate

September 26, 2024

Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial

September 24, 2024

Forecasting The Future: 20 Analyst Projections For Biogen

September 23, 2024

Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know

September 09, 2024

Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'

September 09, 2024

Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges

September 09, 2024

Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder

September 04, 2024

Key Takeaways From Biogen Analyst Ratings

September 04, 2024

These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now

August 31, 2024

Eli Lilly Is The Nvidia Of Weight Loss And GLP-1 Space, Says Roundhill Investments CEO, Emphasizes Market Leadership And Growth Potential Of Zepbound Maker

August 28, 2024

Chinese E-Commerce Giant Drops 35% In 2 Days, But Analysts See 92% Upside Potential

August 27, 2024

Eli Lilly's Alzheimer's Drug Faces UK Agency Block After Biogen's Medicine Rejection Over Cost, Safety

August 26, 2024

Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement

August 22, 2024

Cracking The Code: Understanding Analyst Reviews For Biogen

August 19, 2024

A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.

August 11, 2024

How Is The Market Feeling About Biogen?

August 09, 2024

Biogen (BIIB) Q2 2024 Earnings Call Transcript

August 01, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.